Perseus Proteomics Inc. (TYO:4882)
391.00
+16.00 (4.27%)
Apr 24, 2025, 3:30 PM JST
Perseus Proteomics Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
Revenue | 111.39 | 100 | 94 | 71 | 67 | 85 | Upgrade
|
Revenue Growth (YoY) | 16.03% | 6.38% | 32.39% | 5.97% | -21.18% | -69.09% | Upgrade
|
Cost of Revenue | 16.29 | 13 | 7 | 5 | 4 | 6 | Upgrade
|
Gross Profit | 95.1 | 87 | 87 | 66 | 63 | 79 | Upgrade
|
Selling, General & Admin | 334.76 | 366 | 290 | 231 | 162 | 891 | Upgrade
|
Research & Development | 595.96 | 616 | 494 | 308 | 313 | - | Upgrade
|
Operating Expenses | 933.99 | 982 | 784 | 539 | 475 | 891 | Upgrade
|
Operating Income | -838.89 | -895 | -697 | -473 | -412 | -812 | Upgrade
|
Interest & Investment Income | 0.68 | - | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 16.19 | 16 | 7 | 9 | 1 | -8 | Upgrade
|
Other Non Operating Income (Expenses) | -0.18 | -1 | - | -19 | - | -15 | Upgrade
|
EBT Excluding Unusual Items | -822.21 | -880 | -690 | -483 | -411 | -835 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.05 | - | - | - | - | -5 | Upgrade
|
Asset Writedown | -74.41 | -153 | -95 | -117 | -1 | - | Upgrade
|
Other Unusual Items | -70 | -70 | - | 2 | - | - | Upgrade
|
Pretax Income | -897.35 | -1,103 | -785 | -598 | -412 | -840 | Upgrade
|
Income Tax Expense | 1.4 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
Net Income | -898.75 | -1,104 | -786 | -599 | -413 | -841 | Upgrade
|
Net Income to Common | -898.75 | -1,104 | -786 | -599 | -413 | -841 | Upgrade
|
Shares Outstanding (Basic) | 15 | 12 | 12 | 11 | 7 | 6 | Upgrade
|
Shares Outstanding (Diluted) | 15 | 12 | 12 | 11 | 7 | 6 | Upgrade
|
Shares Change (YoY) | 25.28% | 0.24% | 6.94% | 57.10% | 13.88% | - | Upgrade
|
EPS (Basic) | -66.34 | -93.65 | -66.84 | -54.47 | -59.00 | -136.83 | Upgrade
|
EPS (Diluted) | -66.34 | -93.65 | -66.84 | -54.47 | -59.00 | -136.83 | Upgrade
|
Free Cash Flow | - | -976 | -728 | -509 | -424 | - | Upgrade
|
Free Cash Flow Per Share | - | -82.80 | -61.91 | -46.29 | -60.57 | - | Upgrade
|
Gross Margin | - | 87.00% | 92.55% | 92.96% | 94.03% | 92.94% | Upgrade
|
Operating Margin | -753.15% | -895.00% | -741.49% | -666.20% | -614.93% | -955.29% | Upgrade
|
Profit Margin | -806.88% | -1104.00% | -836.17% | -843.66% | -616.42% | -989.41% | Upgrade
|
Free Cash Flow Margin | - | -976.00% | -774.47% | -716.90% | -632.84% | - | Upgrade
|
EBITDA | -837.39 | -892 | -692 | -471 | - | - | Upgrade
|
D&A For EBITDA | 1.5 | 3 | 5 | 2 | - | - | Upgrade
|
EBIT | -838.89 | -895 | -697 | -473 | -412 | -812 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.